Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine
Dong Sun, Alfonso Eirin, Xiang-Yang Zhu, Xin Zhang, John A Crane, John R Woollard, Amir Lerman, Lilach O Lerman, Dong Sun, Alfonso Eirin, Xiang-Yang Zhu, Xin Zhang, John A Crane, John R Woollard, Amir Lerman, Lilach O Lerman
Abstract
The impact of coronary artery stenosis (CAS) on renal injury is unknown. Here we tested whether the existence of CAS, regardless of concurrent atherosclerosis, would induce kidney injury and magnify its susceptibility to damage from coexisting hypertension (HT). Pigs (seven each) were assigned to sham, left-circumflex CAS, renovascular HT, and CAS plus HT groups. Cardiac and nonstenotic kidney functions, circulating and renal inflammatory and oxidative markers, and renal and microvascular remodeling were assessed 10 weeks later. Myocardial perfusion declined distal to CAS. Systemic levels of PGF2-α isoprostane, a marker of oxidative stress, increased in CAS and CAS plus HT, whereas single-kidney blood flow responses to acetylcholine were significantly blunted only in CAS plus HT compared with sham, HT, and CAS, indicating renovascular endothelial dysfunction. Tissue expression of inflammatory and oxidative markers were elevated in the CAS pig kidney, and further magnified in CAS plus HT, whereas angiogenic factor expression was decreased. Bendavia, a mitochondria-targeted peptide, decreased oxidative stress and improved renal function and structure in CAS. Furthermore, CAS and HT synergistically amplified glomerulosclerosis and renal fibrosis. Thus, mild myocardial ischemia, independent of systemic atherosclerosis, induced renal injury, possibly mediated by increased oxidative stress. Superimposed HT aggravates renal inflammation and endothelial dysfunction caused by CAS, and synergistically promotes kidney fibrosis, providing impetus to preserve cardiac integrity in order to protect the kidney.
Figures
References
- Bitton A, Choudhry NK, Matlin OS, et al. The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med. 2013;126:357 e7–e27.
- Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.
- Kim EJ, Kim S, Kang DO, et al. Metabolic Activity of the Spleen and Bone Marrow in Patients With Acute Myocardial Infarction Evaluated by 18F-Fluorodeoxyglucose Positron Emission Tomograpic Imaging. Circ Cardiovasc Imaging. 2014;7:454–60.
- Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487:325–9.
- Lu J, Wang X, Wang W, et al. Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation. Kidney Int. 2012;82:436–44.
- Appel LJ, Wright JT, Jr, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363:918–29.
- Weber-Mzell D, Kotanko P, Schumacher M, et al. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J. 2002;23:1684–91.
- Liang F, Hu DY, Wu MY, et al. The incidence of renal artery stenosis in the patients referred for coronary artery bypass grafting. Indian J Nephrol. 2012;22:13–7.
- Ollivier R, Boulmier D, Veillard D, et al. Frequency and predictors of renal artery stenosis in patients with coronary artery disease. Cardiovasc Revasc Med. 2009;10:23–9.
- Macedo TA, Pedrosa RP, Costa-Hong V, et al. Renal artery stenosis predicts coronary artery disease in patients with hypertension. PLoS One. 2013;8:e58635.
- Khangura KK, Eirin A, Kane GC, et al. Cardiac function in renovascular hypertensive patients with and without renal dysfunction. Am J Hypertens. 2014;27:445–53.
- Khangura KK, Eirin A, Kane GC, et al. Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension. J Hypertens. 2014;32:1300–6.
- Bidani AK, Polichnowski AJ, Loutzenhiser R, et al. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens. 2013;22:1–9.
- Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 2008;17:266–70.
- Rodriguez-Porcel M, Krier JD, Lerman A, et al. Combination of hypercholesterolemia and hypertension augments renal function abnormalities. Hypertension. 2001;37:774–80.
- Ruparelia N, Digby JE, Jefferson A, et al. Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflamm Res. 2013;62:515–25.
- Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31:703–11.
- Heywood JT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422–30.
- Urbieta-Caceres VH, Lavi R, Zhu XY, et al. Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney. Am J Physiol Renal Physiol. 2010;299:F135–40.
- Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44:595–601.
- Zhu XY, Daghini E, Chade AR, et al. Role of oxidative stress in remodeling of the myocardial microcirculation in hypertension. Arterioscler Thromb Vasc Biol. 2006;26:1746–52.
- Sun D, Bu L, Liu C, et al. Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction. PLoS One. 2013;8:e65042.
- Urbieta-Caceres VH, Zhu XY, Jordan KL, et al. Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. Atherosclerosis. 2012;221:350–8.
- Chade AR, Zhu X, Lavi R, et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation. 2009;119:547–57.
- Chade AR, Zhu X, Mushin OP, et al. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J. 2006;20:1706–8.
- Eirin A, Ebrahimi B, Zhang X, et al. Changes in Glomerular Filtration Rate After Renal Revascularization Correlate With Microvascular Hemodynamics and Inflammation in Swine Renal Artery Stenosis. Circulation: Cardiovascular Interventions. 2012;5:720–8.
- Urbieta Caceres VH, Lin J, Zhu XY, et al. Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. Am J Physiol Heart Circ Physiol. 2011;300:H693–701.
- Favreau F, Zhu XY, Krier JD, et al. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure. Kidney Int. 2010;78:1110–8.
- Chade AR, Rodriguez-Porcel M, Herrmann J, et al. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol. 2004;15:958–66.
- Daghini E, Primak AN, Chade AR, et al. Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. Radiology. 2007;243:405–12.
- Muczynski KA, Cotner T, Anderson SK. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. Kidney Int. 2001;59:488–97.
- Chade AR, Mushin OP, Zhu X, et al. Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia. Hypertension. 2005;46:772–9.
- Nangaku M, Alpers CE, Pippin J, et al. CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats. J Am Soc Nephrol. 1998;9:590–7.
- Ebrahimi B, Eirin A, Li Z, et al. Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of Swine atherosclerotic renal artery stenosis. PLoS One. 2013;8:e67474.
- Eirin A, Zhu XY, Urbieta-Caceres VH, et al. Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am J Physiol Renal Physiol. 2011;300:F1394–401.
- Chade AR, Rodriguez-Porcel M, Grande JP, et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol. 2003;23:1295–301.
- Eirin A, Li Z, Zhang X, et al. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension. 2012;60:1242–9.
Source: PubMed